Pasipanodya, J. G., & Gumbo, T. (2010). Clinical and Toxicodynamic Evidence that High-Dose Pyrazinamide Is Not More Hepatotoxic than the Low Doses Currently Used. American Society for Microbiology (ASM).
Παραπομπή Chicago StylePasipanodya, Jotam G., και Tawanda Gumbo. Clinical and Toxicodynamic Evidence That High-Dose Pyrazinamide Is Not More Hepatotoxic Than the Low Doses Currently Used. American Society for Microbiology (ASM), 2010.
Παραπομπή MLAPasipanodya, Jotam G., και Tawanda Gumbo. Clinical and Toxicodynamic Evidence That High-Dose Pyrazinamide Is Not More Hepatotoxic Than the Low Doses Currently Used. American Society for Microbiology (ASM), 2010.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.